Results 121 to 130 of about 350 (140)

RAZOXANE IN THE TREATMENT OF PSORIASIS

British Journal of Dermatology, 1980
G W, Hill, M, Roach
openaire   +2 more sources

Razoxane *

Clinical and Experimental Dermatology, 1981
openaire   +2 more sources

Razoxane and T-cell lymphoma

British Journal of Dermatology, 1989
A.G. Zuiable, H. Aboud, I. Coulson, J.G. Treleaven, R.L. Powles   +4 more
openaire   +1 more source

Razoxane

Reactions, 1987
openaire   +1 more source

Razoxane

Reactions, 1989
openaire   +1 more source

Use of Razoxane as a radiosensitizer for the treatment of soft tissue sarcomas

Expert Review of Anticancer Therapy
Razoxane, discovered in the 1960s, was evaluated as a topoisomerase II inhibitor to treat cancer. Cancer therapeutic models of the mid-1900's were based on the following three assumptions: treatment agents should demonstrate activity as a single agent, should reduce tumor size, or could exacerbate tumor hypoxia.
openaire   +2 more sources

Inoperable recurrent rectal cancer: Results of a prospective trial with radiation therapy and razoxane

International Journal of Radiation Oncology Biology Physics, 1994
Walter Rhomberg, Helmut Eiter
exaly  

RAZOXANE IN PSORIASIS

InPharma, 1976
openaire   +1 more source

Treatment of Vascular Soft Tissue Sarcomas With Razoxane, Vindesine, and Radiation

International Journal of Radiation Oncology Biology Physics, 2009
Walter Rhomberg, Boris Pokrajac, Helmut Eiter   +2 more
exaly  

Combined Razoxane and Radiotherapy for Melanoma Brain Metastases. A Retrospective Analysis

Journal of Neuro-Oncology, 2005
Walter Rhomberg, Helmut Eiter, Christoph Saely   +2 more
exaly